Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Exp Obstet Gynecol ; 32(1): 49-51, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15864938

RESUMO

PROBLEM: The aim of this study was to evaluate the effects of two different prophylactic protocols, low-dose aspirin and fish oil derivates, in the treatment of patients with recurrent pregnancy loss associated with antiphospholipid antibodies (APA) syndrome. METHODS: A prospective study included 30 patients who were alternately assigned to treatment. Each patient had had at least two consecutive spontaneous abortions, positive antiphospholipid antibodies on two occasions, and a complete evaluation. RESULTS: Among patients treated with low-dose aspirin, 12 out of the 15 (80%) pregnancies ended in live births. In the fish oil derivate group 11 out of the 15 (73.3%) ended in live births (p > 0.05). There were no significant differences between the low-dose aspirin and the fish oil derivates groups with respect to gestational age at delivery (39.9 +/- 0.4 vs 39 +/- 1.5 weeks), fetal birth weight (3290 +/- 200g vs 3560 +/- 100 g), number of cesarean sections (25% vs 18%), or complications. CONCLUSION: There were no significant differences in terms of pregnancy outcome between women with recurrent pregnancy loss associated with APA syndrome treated with low-dose aspirin or fish oil derivates.


Assuntos
Aborto Habitual/prevenção & controle , Síndrome Antifosfolipídica/complicações , Aspirina/uso terapêutico , Ácidos Docosa-Hexaenoicos/uso terapêutico , Ácido Eicosapentaenoico/uso terapêutico , Inibidores da Agregação Plaquetária/uso terapêutico , Aborto Habitual/etiologia , Adulto , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Feminino , Humanos , Gravidez , Resultado da Gravidez , Estudos Prospectivos , Trombose/prevenção & controle
2.
Clin Exp Obstet Gynecol ; 31(1): 47-9, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-14998188

RESUMO

Maternal infective processes sustained especially by Gram-negative anaerobic bacteria like periodontal disease, during pregnancy, have been demonstrated to perturb the physiologic course of parturition through inflammatory cytokine production, sometimes resulting in preterm labor, preterm premature rupture of membranes and preterm low birth weight. In a matched case-control study, the hypothesis that poor oral health of pregnant women is a risk factor for low birth weight (LBW) was evaluated. Gingival crevicular fluid levels of PGE2 and IL-1beta were measured in order to determine whether mediator levels were related to current pregnancy outcome. Results indicate that GCF-PGE2 and GCF-IL-1beta levels are significantly higher in preterm low birth weight (PLBW) mothers as compared with normal birth weight controls. The data confirm that there is a possible correlation between periodontal problems typical of pregnancy and the occurrence of complications such as preterm low birth weight.


Assuntos
Líquido do Sulco Gengival/química , Periodontite/complicações , Complicações na Gravidez , Resultado da Gravidez , Estudos de Casos e Controles , Dinoprostona/metabolismo , Feminino , Ruptura Prematura de Membranas Fetais/metabolismo , Gengiva/metabolismo , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Mediadores da Inflamação/metabolismo , Interleucina-1/metabolismo , Periodontite/metabolismo , Gravidez , Complicações na Gravidez/metabolismo , Complicações na Gravidez/microbiologia
3.
Artigo em Inglês | MEDLINE | ID: mdl-12052045

RESUMO

Anandamide (N -arachidonoylethanolamine, AEA) is a major endocannabinoid, shown to impair mouse pregnancy and embryo development and to induce apoptosis in blastocysts. Here, we review the roles of AEA, of the AEA-binding cannabinoid (CB) receptors, of the selective AEA membrane transporter (AMT), and of the AEA-hydrolyzing enzyme fatty acid amide hydrolase (FAAH), in human gestation. In particular, we discuss the interplay between the endocannabinoid system and the hormone-cytokine array involved in the control of human pregnancy, showing that the endocannabinoids take part in the immunological adaptation occurring during early pregnancy. In this line, we discuss the critical role of FAAH in human peripheral lymphocytes, showing that the expression of this enzyme is regulated by progesterone, Th1 and Th2 cytokines, which also regulate fertility. Moreover, we show that AEA and the other endocannabinoid, 2-arachidonoylglycerol, inhibit the release of the fertility-promoting cytokine leukemia inhibitory factor from human lymphocytes. Taken together, low FAAH and consistently high blood levels of AEA, but not CB receptors or AMT, can be early (<8 weeks of gestation) markers of spontaneous abortion, potentially useful as diagnostic tools for large-scale, routine monitoring of gestation in humans.


Assuntos
Canabinoides/metabolismo , Citocinas/metabolismo , Eicosanoides/metabolismo , Fertilidade , Hormônios/metabolismo , Gravidez/metabolismo , Animais , Moduladores de Receptores de Canabinoides , Endocanabinoides , Feminino , Humanos , Linfócitos/metabolismo , Receptores de Canabinoides , Receptores de Droga/agonistas , Receptores de Droga/metabolismo
4.
FEBS Lett ; 507(1): 30-4, 2001 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-11682054

RESUMO

Spermine is shown to uncouple isolated mitochondria and to trigger the selective release of cytochrome c. Pargyline, an inhibitor of amine oxidase (AO), fully prevented these effects of spermine, which instead were potentiated by exogenous AO. Hydrogen peroxide, an oxidation product of spermine, mimicked the effects of spermine on mitochondria, while the addition of catalase prevented them. Spermidine and putrescine also caused mitochondrial uncoupling and triggered cytochrome c release, with a potency which correlated with the substrate preference of mitochondrial AO. Pargyline protected human lymphoma U937 cells against UVB-induced apoptosis, by reducing AO activity, mitochondrial uncoupling and cytochrome c release.


Assuntos
Poliaminas Biogênicas/metabolismo , Grupo dos Citocromos c/metabolismo , Mitocôndrias/metabolismo , Amina Oxidase (contendo Cobre)/antagonistas & inibidores , Animais , Apoptose/efeitos dos fármacos , Poliaminas Biogênicas/farmacologia , Inibidores Enzimáticos/farmacologia , Feminino , Humanos , Técnicas In Vitro , Potenciais da Membrana/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Oxirredução , Pargilina/farmacologia , Ratos , Ratos Wistar , Espermina/metabolismo , Espermina/farmacologia , Células U937 , Desacopladores/metabolismo , Desacopladores/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...